Tenon Medical, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Tenon Medical, Inc. on November 7, 2023, covering events occurring on November 1, 2023. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Los Gatos, California. Its common stock (TNON) and warrants (TNONW) trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance action rather than financial performance results.
Material Changes
The primary material change reported is a 1-for-10 reverse stock split of the Company's common stock. Key details include:
- Effective Date: The split became effective at 12:01 a.m. on November 2, 2023.
- Implementation: Filed via a Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on November 1, 2023.
- Fractional Shares: No fractional shares will be issued; fractional amounts will be rounded up to one whole share.
Guidance, Outlook, and Risks
The filing references a press release issued on October 31, 2023, regarding the reverse stock split but does not contain specific management commentary on future financial guidance, operational outlook, or new risk factors within the text provided. The Company notes that the description of the amendment is qualified by reference to the full Certificate of Amendment filed as Exhibit 3.1.
Investor Verification Checklist
- Verify the adjusted share count and trading price of TNON and TNONW following the 1-for-10 split effective November 2, 2023.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for any additional provisions regarding the split.
- Confirm the treatment of fractional shares for specific shareholder accounts to ensure rounding up was applied correctly.
- Check subsequent filings for any impact of the split on Nasdaq listing compliance or warrant exercise ratios.